Navigation Links
Breakthrough Solution Found in Refresh Skin Care Products
Date:3/9/2009

World-renowned Dr. Susan Evans debuts newest addition to collection of proven skincare products

BEVERLY HILLS, Calif., March 9 /PRNewswire/ -- It's not necessary to be a Hollywood celebrity to have great skin. Thanks to Dr. Susan Evans, the world-renowned Beverly Hills-based innovator of Refresh Skin Care (http://www.refreshskin.com) products, people from all walks of life can enjoy the benefits of a beautiful, healthy-looking visage. That starts with one of Dr. Evans' most popular product lines, Refresh Acne Clear, plus a new, breakthrough solution for removing dark circles from under the eyes: EpiLight Eye Cream.

"People everywhere agonize over acne and other skin problems," says Dr. Evans, the Harvard-trained dermatologist and co-owner of Cosmetic Physicians of Beverly Hills. "With products such as Refresh Acne Clear, I'm clearing up the face, and then eliminating pesky dark circles under the eyes with EpiLight Eye Cream. The results are amazing: a brighter, more energetic, youthful look."

While other eye creams on the market only address wrinkles, EpiLight Eye Cream inhibits pigment formation through two key active ingredients: Licorice Extract and Niacin (Nicatinimide). EpiLight Eye Cream minimizes dark tones within three days of application and produces major results within six weeks. It's also safe -- EpiLight Eye Cream consists of natural ingredients and doesn't include Hydroquinone, a controversial agent found in other eye-lightening creams.

"I'm thrilled to introduce EpiLight Eye Cream because it combats dark circles under the eyes in a non-toxic, preventative way," Dr. Evans says. "It's the Refresh Skin Care mission to provide smart solutions for skin-care concerns, and that's also why my Refresh Acne Clear has been wildly popular. Its effectiveness as a long-lasting, proactive skin-care system is proven."

'/>"/>
SOURCE Refresh Skin Care
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
2. TB breakthrough could lead to stronger vaccine
3. Prosthetic Center of Excellence to Provide Breakthrough Technology to Rehabilitation Patients
4. Neurologist to Announce Breakthrough Headache Treatment
5. Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) Appetite Control Formula
6. Breakthrough Rx for Relationships Offers Hope
7. Oklahoma State University researchers make breakthrough against poxviruses
8. DHA Hailed as Breakthrough Treatment for Lowering Risk of Developmental Disorders in Premature Infants; Animi-3(R) Prescribed to Women Who Are Not Eating Fish
9. Canine Cancer #1 Fear of Dog Lovers, Web Exclusive by Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners
10. American Asthma Foundation Announces Breakthrough Discovery
11. A breakthrough in diagnosis of enteric lesions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Not sure how to optimize your Emergency Depar...H1N1 influenza cases this season? Should you test...ould you use? Which - if any - antiviral should yo...09 issue of Emergency Medicine Practice, which pre...resources on influenza diagnosis and treatment. ,...
(Date:11/25/2009)... BenefitPackages.com, California,s designated ...to raise awareness during the November 15 - Decemb...lows them to enroll in a zero-cost PPO Medicare Ad...lue Cross are available through BenefitPackages.co... Calabasas, CA (PRWEB) November 25, 2009...
(Date:11/24/2009)...esidents generally provide accurate preliminary in...after hours when attending neuroradiologist unavai...rmed at a level I trauma center published in the D...ege of Radiology ( JACR ). , The accuracy of i...of diagnostic radiology. In most training programs...
(Date:11/24/2009)...rs from Boston University School of Medicine (BUSM... Department have identified a number of proteins w... cancer and normal cells with almost 97 percent ac...oped a new computational strategy to analyze this ...ways (molecular circuits) that are active in cance...
(Date:11/24/2009)...Nov.24/PRNewswire/--Quantros,aleadinghealthcareana...r,announcedtodaythatithaslicensedintellectualprope...MichiganforintegrationintoQuantros,suiteofsafetyan...sity,ssoftwarewithintheSRMproductfamilywillenablea...oughutilizationofahealthcareprovider,sintegratedad...
Breaking Medicine News(10 mins):Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 2Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 3Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2
...arning pharmaceutical manufacturers, suppliers, dr...d medications to be especially vigilant in assuri...ide in liquid over-the-counter and prescription dr... guidance to industry recommending methods of test...
...lkers in the world, as the speed at which the city...st decade. In a sample of 32 cities around...itizens of Copenhagen, Madrid and Guangzhou in Chi...ut walking fast is not good for you, according to ...
... to fight against cancer for the fifth time . ...iagnosed with cancer for the fifth time, started a...cerous nodules were discovered in his lungs. ...ever had but I have fought hard throughout my life...
...tates appears to be strongly associated with incre... study. Dr. Winchester and colleagues fou... and nitrates measurements in surface water were h... from 1996-2002. Preterm birth varied from a high ...
...e trauma abdomen and pelvis CT compared to plain r... by radiologists at the University of Cincinnati. ...derwent plain radiographs and abdomen and pelvis C...ccording to the study, 180 (19.3%) of the patients...
...y rankings of the fattest cities, the fittest citi... cities . Now, in the first-of-its-kind survey, th...he cities that take sun protection seriously and t...s spanning 29 states on their knowledge, attitudes...
Other Medicine News:Health News:FDA Advises Manufacturers to Test Glycerin for Possible Contamination 2Health News:Bobby Robson Diagnosed With Cancer for Fifth Time 2Health News:Premature Birth Linked With Increased Use of Pesticides 2Health News:New Survey List Out Cities That Take Sun Protection Seriously 2Health News:New Survey List Out Cities That Take Sun Protection Seriously 3
(Date:11/24/2009)...re-Asia/--ChindexInternational,Inc.,("Chindex")(Na...Western,healthcareproductsandservicesinthePeople,s...ttendthe21stAnnualPiperJaffray,"Unplugged"HealthCa...kPalaceHotel. , Managementiscurrentlyschedule...holdone-on-onemeetingsthroughouttheday.Awebcast,of...
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...wire/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp...search(NYSE: SI ),todayannouncedthatitsZargisCardi...fCBS, TheEarlyShow duringasegmentinwhichMarkJannot...inningproductsfromthepublication,s2009"BestofWhat,...elevisionmorningnewstalkshowbroadcastbyCBSfromNewY...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Kidney Transplant at 84 Chicago Artist Proves New Start Possible at Any Age 57637 1Kidney Transplant at 84 Chicago Artist Proves New Start Possible at Any Age 57637 2Kidney Transplant at 84 Chicago Artist Proves New Start Possible at Any Age 57637 3Kidney Transplant at 84 Chicago Artist Proves New Start Possible at Any Age 57637 4MedWaves Inc Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation Ablation System for Treatment of Tumors in Live 57634 1MedWaves Inc Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation Ablation System for Treatment of Tumors in Live 57634 2MedWaves Inc Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation Ablation System for Treatment of Tumors in Live 57634 3MedWaves Inc Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation Ablation System for Treatment of Tumors in Live 57634 4Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 1Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 2Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 3
...ned Alone and in Combination with Chemotherapy, F...., a,development-stage pharmaceutical company disc...i)-based therapeutics, today announced that the,jo...y of siRNA targeting,its proprietary target gene a...dition dated October 1, 2008. The paper, entitled ...
...Prophylaxis Treatment with Kogenate FS Reduces the...ren with No Pre-Existing,Joint Damage, BERKELEY, ...day that the U.S. Food and Drug Administration (FD...R) FS Antihemophilic Factor,(Recombinant) to reduc...of,joint damage in patients aged 0-16 years with s...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: